Science, Computers & Technology Civil Procedure Government Contracting

False Claims Act (FCA) Pharmaceutical Industry Qui Tam Prescription Drugs Dismissals Whistleblowers FDA Fraud Medical Devices Federal Contractors Medicaid Off-Label Promotion Pleading Standards Popular Compliance DOJ First-to-File Healthcare Manufacturers Off-Label Use Patents Pharmacies Relators Anti-Kickback Statute Appeals Attorney-Client Privilege Corporate Counsel Direct Infringement Federal Rules of Civil Procedure GSA Health Care Providers Motion to Amend Motion to Dismiss Novartis Omnicare Patent Infringement Patent Litigation Preliminary Injunctions Public Disclosure SCOTUS Trade Agreements Act TSA Abbott Laboratories Administrative Procedure Act Affirmative Defenses Affordable Care Act Amarin Amended Complaints American Bar Association (ABA) Aviation Industry Bayh-Dole Act Board of Directors Bristol-Myers Squibb Burden of Proof Certifications Chief Compliance Officers Civil Monetary Penalty Class Action Confidential Information Construction Industry Coupons Cyber Attacks Cyber Crimes Cybersecurity Damages Data Breach Data Privacy Data Protection Data Security Davis-Bacon Act Declaratory Relief Distributors Evidence Exclusive Remedy False Billing False Statements First Amendment First-Filed Action Rule Fraud in the Inducement Free Speech Frivolous Lawsuits Generic Drugs Hackers Healthcare Fraud Indirect Infringement Induced Infringement Interstate Commerce Investigations KBR (formerly Kellogg Brown & Root) Kickbacks Legal Ethics License Agreements Licenses Litigation Strategies Long Term Care Facilities Medicare Medicare Part D Medtronic Misappropriation Misbranding Misleading Statements Narcotics NIH OIG OPM Overpayment PHI Prescription Drug Coverage Privilege Waivers Purchase Price Risk Management Rule Rule 9(b) Sealed Records Service Contract Act Social Security Administration (SSA) Software Statistical Sampling Stem cells Subpoenas Supplemental Information Suppliers Supply Chain Threshold Requirements Trade Secrets